ACR 2022 Tweet by Robert B Chao, MD

Tweet
Robert B Chao, MD @doctorRBC Nov 12, 2022
View on
Important to remember to screen for cancer in patients with idiopathic inflammatory myopathy, esp in high risk pts! Can even consider PET/CT, CT, pelvic US, initially. Question is... will insurances approve all of these tests?
Abs#0002 @RheumNow #ACR22
Image from Robert B Chao, MD’s tweet

Related Content

Article Drug Safety

Neoplasia and Autoimmune Disease

Jack Cush, MD Apr 27, 2026
Malignancy rivals cardiovascular disease as a leading cause of death in patients with systemic autoimmune diseases. Chronic inflammation and immune dysregulation can drive oncogenesis, while antitumor immune responses can trigger autoimmune phenomena (paraneoplastic syndromes, checkpoint inhibitor-induced rheumatic disease).
Article Education/ACR/EULAR

Treating Obesity is Disease-Modifying (9.4.2026)

Jack Cush, MD Sep 4, 2026
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  New drugs approved, new drugs halted and some drugs out of control. Ready to test your knowlege? Take this week's quiz!FDA Approves Brepocitinib to Treat DermatomyositisNovartis & BMS CAR-T Cell Trials…
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Topics

×